In our study, AT1R blockade administration promoted normalization of the metabolic and cardiovascular disturbances, including cardiac remodeling and insulin resistance, arising from hypercaloric diet-induced obesity. The gene discussed is AGTR1; the disease is obesity due to melanocortin 4 receptor deficiency.